How to License a Patent: Royalty Rates, License Types, and How to Find Licensees
Patent licensing is the process of granting another party the right to use your patent in exchange for royalty payments, while you retain ownership. The standard royalty rate for a patent license is 3–10% of net sales of the licensed product, depending on technology category, exclusivity, and the licensee's market position. Unlike selling a patent outright, patent licensing generates recurring income from multiple users simultaneously — a patent that sells for $150,000 might generate $30,000–50,000 per year in royalties over its remaining life.
What Is Patent Licensing?
A patent license is a contractual grant of rights that allows another party — the licensee — to make, use, sell, or import the patented invention, in exchange for payment to the patent holder. The license does not transfer ownership of the patent. The patent holder (licensor) retains the patent and can grant licenses to multiple parties simultaneously.
Patent licensing differs from selling (patent assignment) in one fundamental way: ownership stays with the inventor. This distinction determines everything else — payment structure (recurring vs. one-time), income potential (uncapped vs. capped), and responsibility (the inventor remains responsible for maintenance fees and enforcement).
Patent licensing revenue — income generated through royalties — is one of the primary ways patent portfolios generate value for corporations, universities, and individual inventors. IBM, Qualcomm, and Interdigital each generate billions annually in patent licensing income from portfolios of thousands of patents. The same economic model applies at any scale: a single inventor with one well-structured license can generate consistent annual income for the remaining life of the patent.
Patent licensing strategy determines which licenses to grant (exclusive vs. non-exclusive), to which parties, on what terms, and for what applications. Getting the strategy right before approaching any licensee determines whether you maximize value or leave significant money on the table.
Patent Licensing vs. Selling: Which Is Right for You?
The decision between patent licensing vs. selling depends on three factors: how much remaining life your patent has, how many potential users exist in your technology space, and whether you need immediate liquidity or prefer recurring income. The table below compares every relevant dimension.
| Factor | Selling (Assignment) | Licensing |
|---|---|---|
| Ownership after transaction | Transferred permanently to buyer | Retained by inventor |
| Payment structure | One-time lump sum | Recurring royalties (3–10% of net sales) or lump-sum license fee |
| Income potential | Capped at sale price (one transaction) | Uncapped — multiple licensees, recurring payments |
| Example: $150K patent | One payment of $150,000 | $30,000–$50,000/year for remaining patent life |
| Time to first payment | 30–90 days (with AI marketplace) | 3–12 months to negotiate and close first license |
| Transaction complexity | Single assignment agreement + USPTO recordation | Separate license agreement per licensee; ongoing royalty tracking |
| Enforcement responsibility | Buyer enforces against infringers | Patent holder remains responsible for enforcement |
| Best for | Immediate liquidity, complex enforcement, patent nearing expiration | Strong claims, multiple potential users, remaining life > 7 years |
| Ipiry commission | 4–7.5% of sale price (one time) | Success fee on licensing transactions (see /pricing) |
For patents with 7+ years of remaining life and multiple potential users, licensing typically generates more total value than a single sale. For patents with under 5 years remaining or complex enforcement landscapes, selling is usually the better path. Complete selling guide →
Types of Patent Licenses: Exclusive, Non-Exclusive, and Field-of-Use
Choosing the right license type is the most consequential strategic decision in patent licensing. It determines your royalty rate, your income diversification, and your future flexibility.
Exclusive License
An exclusive patent license grants one licensee the sole right to use the patent in a defined field or territory — no other company can be licensed for that specific use during the exclusivity period. In exchange for exclusivity, the licensee typically pays 2–3x the royalty rate of a comparable non-exclusive license, and often pays a significant upfront license fee in addition to running royalties.
Best for: Patents with one dominant potential user, or when the licensee needs to make large capital investments justified only by exclusivity. Risk: if the licensee underperforms, you are locked in. Mitigation: include minimum royalty provisions and performance milestones.
Non-Exclusive License
A non-exclusive patent license allows multiple licensees to use the same patent simultaneously, each paying independent royalties. This is the most common license structure for broad technology patents because it maximizes the licensor's total income — multiple streams from multiple users, uncapped. Non-exclusive royalty rates are lower per licensee but aggregate across all licensees.
Best for: Patents covering technology used across an industry (software methods, communications protocols, component designs). A single non-exclusive license does not foreclose future opportunities.
Field-of-Use License
A field-of-use restriction limits the licensee's right to use the patent to a specific application, market, or customer segment. The same patent can be licensed exclusively to Company A for video streaming, exclusively to Company B for data backup, and non-exclusively to others for general computing — all simultaneously. Field-of-use segmentation allows patent holders to capture maximum value from each market segment independently.
Best for: Patents covering platform technologies applicable across multiple industries. Requires careful drafting to ensure fields do not overlap and create accidental exclusivity conflicts.
Sublicense
A sublicense is a grant of rights from a licensee to a third party. Whether a licensee can sublicense depends entirely on the original license agreement — sublicense rights must be explicitly granted. Sublicensing can significantly multiply your patent's reach (and your royalty income) if the licensee is a platform company whose sublicensees use the technology at scale. However, uncontrolled sublicensing can dilute exclusivity and reduce the value of your license grants to other parties.
Patent Royalty Rates: What to Charge
The patent royalty rate is the percentage of net sales the licensee pays the patent holder for each unit sold using the licensed technology. Standard rates range from 2–10% depending on technology category, exclusivity, patent strength, and the licensee's margin. The Georgia-Pacific factors — a 15-factor legal framework established in Georgia-Pacific Corp. v. U.S. Plywood Corp. (1970) — are the standard reference for determining a reasonable royalty in litigation, and inform negotiated rates as well.
The table below shows standard patent royalty ranges by CPC technology category, derived from Ipiry's analysis of KPSS transaction data and Licensing Executives Society (LES) survey benchmarks.
| CPC Category | Standard Royalty Range | Exclusive License Premium | Lump-Sum Range |
|---|---|---|---|
| G06F — Computing / Software | 3–5% of net sales | 2–3x non-exclusive rate | $25,000–$200,000 |
| G06N — AI / Machine Learning | 4–6% of net sales | 2–3x | $50,000–$400,000 |
| H04L — Network Communications | 3–5% of net sales | 1.5–2.5x | $30,000–$250,000 |
| H04W — Wireless / Mobile | 2–4% of net sales | 1.5–2x | $20,000–$150,000 |
| A61B — Medical Devices | 5–10% of net sales | 2–3x | $100,000–$500,000 |
| G06Q — Business Methods | 2–4% of net sales | 1.5–2x | $15,000–$100,000 |
| H01L — Semiconductors | 2–4% of net sales | 2–3x | $50,000–$300,000 |
| B60W — Autonomous Vehicles | 4–8% of net sales | 2–3x | $100,000–$600,000 |
Royalty rate ranges derived from Ipiry's analysis of KPSS patent transaction data, LES survey benchmarks, and Richardson Oliver Consulting Group IP transaction reports. Rates represent market ranges, not legal determinations of reasonable royalty. Updated April 2026.
Patent License Structures: Running Royalty vs. Lump Sum
Running Royalty
A running royalty is an ongoing payment calculated as a percentage of the licensee's net sales of products incorporating the licensed patent. Payments are typically made quarterly or annually, often with minimum annual royalty commitments. Running royalties are better when the licensee's sales are uncertain or growing — you share in the upside as the product succeeds.
Requires: Audit rights in the license agreement to verify reported sales. Standard audit right: licensor may audit books once per year with 30 days notice.
Lump-Sum License
A lump-sum license is a one-time upfront payment for the right to use the patent for its remaining life (or a specified term). It provides immediate certainty and eliminates the need for ongoing royalty reporting. Lump-sum is better when you want immediate payment, the licensee's sales volume is predictable, or administrative simplicity is valued.
Hybrid structure: An upfront license fee plus ongoing running royalties is common in high-value deals. The upfront fee compensates for the risk of granting exclusivity; the running royalty provides ongoing upside.
How to License a Patent to a Company: 5 Steps
The process from identifying licensees to signing a license agreement. Ipiry automates Steps 2 and 3.
Get a Patent Valuation
Before approaching any company, establish your royalty anchor — the credible basis for your royalty rate ask. Without a documented valuation, licensees consistently anchor negotiations below fair market value. Ipiry's free AI valuation compares your patent against 652,000 KPSS comparable transactions and returns a market value range in 60 seconds. Use this range to derive your royalty rate: divide the estimated annual value contribution by the licensee's projected licensed sales.
Get free patent valuation →Identify Potential Licensees
Find companies already using your patented technology — either knowingly (as a design choice) or unknowingly (as potential infringers). The most reliable sources: (1) forward citations on your patent — companies that cite your patent are aware of the technology; (2) product research in your CPC category — search for products using the same method or apparatus; (3) Ipiry's AI buyer matching, which cross-references your patent's claims against a database of active acquirers and licensees. Infringement analysis → and licensee identification are the same process run from different directions.
Build an Evidence-of-Use Chart
An evidence-of-use (EoU) chart is a claim-by-claim document showing how a specific company's product performs each element of your patent claims. It is the single most effective tool for initiating a licensing discussion — it transforms a licensing request from a speculative ask into a documented business proposition. Companies that receive a well-constructed EoU chart are significantly more likely to engage in licensing negotiations than those that receive a generic licensing inquiry letter.
Build an Evidence-of-Use Chart →Approach and Negotiate
Contact the target company's IP licensing department or general counsel with your EoU evidence and royalty proposal. Lead with the EoU data — evidence of actual use is the strongest opener. Negotiations typically focus on: royalty rate (anchor from your valuation), scope (exclusive vs. non-exclusive, field of use, territory), term (remaining patent life or defined period), payment structure (running royalty vs. lump sum), and minimum royalty commitments. Most software licensing negotiations conclude in 3–9 months; medical device negotiations often take 12–18 months.
Execute the License Agreement
Engage a registered patent attorney to draft or review the patent license agreement. The agreement must include: licensed patent numbers, scope (exclusive/non-exclusive, field, territory), royalty structure (rate, base, frequency), audit rights, sublicense rights or restrictions, representations and warranties, term and termination conditions, and dispute resolution procedures. Do not use a generic template — patent license agreements require precise language to avoid costly ambiguity.
How to Find Patent Licensees
Finding qualified licensees is the hardest part of the licensing process — and the step that most inventors get wrong. Generic outreach letters to random companies rarely generate responses. The approach that works: identify companies with documented evidence of using your technology, then present that evidence.
Forward Citations
Every company that cites your patent in their own patent application is aware of your invention and has built something in the same technology space. These are your highest-probability licensing targets.
Infringement Detection
Companies whose products perform every element of your patent claims are potential infringers — and the strongest candidates for a licensing approach. Ipiry's EoU analysis identifies these automatically.
AI Buyer Matching
Ipiry's AI cross-references your patent's CPC category, claim language, and technology profile against a database of active corporate IP teams, licensing-receptive companies, and repeat patent acquirers.
For developers and AI agents:
Initiate licensing outreach: POST /api/listings with {patent_number, listing_type: "license", license_type: "exclusive" | "non_exclusive", royalty_rate_percent}. Returns {listing_id, listing_url, matched_licensees_count}.
Get royalty benchmark: GET /api/valuations/royalty-benchmark with {cpc_category}. See llms.txt.
How to Negotiate a Patent License
Negotiation begins with your royalty anchor — the documented valuation and royalty rate range that justifies your ask. Without an anchor, you are negotiating on the licensee's terms. With one, you have a credible, data-backed opening position. KPSS data shows patent holders who enter licensing negotiations with documented valuations achieve 30–40% higher settlement rates than those without.
Lead with Evidence
Present your EoU chart first — evidence of actual use eliminates the licensee's ability to claim the patent is not relevant to their product. The negotiation starts from 'how much' not 'whether'.
Anchor High
Your first royalty rate ask should be at the top of the market range for your CPC category. Licensees will negotiate down; anchoring high determines where you land.
Offer Field-of-Use Flexibility
If the licensee resists your rate, consider narrowing the field of use rather than reducing the rate. This preserves your ability to license other fields at full rate to other parties.
Include Minimum Royalties
For exclusive licenses, require minimum annual royalties regardless of sales. This protects against a licensee sitting on your patent without commercializing it. Standard minimum: 50–70% of projected first-year royalties.
Patent License Agreement: What It Must Include
A patent license agreement is the legally binding contract that establishes the terms under which the licensee may use your patent. It is the most important document in the licensing process. A poorly drafted agreement — ambiguous scope, missing audit rights, undefined sublicense provisions — can cost more than the license is worth to resolve.
| Required Term | What It Must Specify |
|---|---|
| Licensed Patents | Patent numbers, including continuation and divisional applications. Specify whether future related patents are included. |
| License Scope | Exclusive or non-exclusive; field of use; territory (US only, worldwide, specific countries); whether sublicensing is permitted. |
| Royalty Structure | Rate (percentage of net sales), definition of net sales (deductions allowed), payment frequency (quarterly/annual), and currency. |
| Minimum Royalties | Annual minimum payment regardless of sales, especially for exclusive licenses. Prevents licensee from sitting on the patent without commercializing. |
| Audit Rights | Licensor's right to audit licensee's books to verify reported sales. Standard: once per year with 30 days notice. Audit costs borne by licensee if discrepancy exceeds 5%. |
| Sublicense Rights | Whether licensee may grant sublicenses, to whom, and whether licensor receives a share of sublicense revenue. |
| Term and Termination | Duration (remaining patent life or fixed term), termination for cause (material breach), termination for convenience provisions. |
| Representations & Warranties | Patent validity, ownership, no prior conflicting licenses. Licensor's warranty that they have the right to grant the license. |
Patent license agreements must be drafted or reviewed by a registered patent attorney. Use Ipiry to find and approach licensees; use counsel to execute the agreement.
Patent Cross-Licensing
Patent cross-licensing is a mutual licensing arrangement in which two patent holders grant each other rights to use their respective patents, often with no cash payment — each party's patent rights offset the other's. Cross-licensing is common in technology industries where multiple companies hold overlapping patents and assertion by either party would be mutually destructive.
For individual inventors, cross-licensing is less common but can be valuable when approaching a company that holds patents in the same technology space. Offering a cross-license can reduce the licensee's resistance to paying royalties by eliminating the asymmetry of the deal. However, cross-licensing effectively caps your royalty income at zero from that party — evaluate carefully before proposing it.
Which Licensing Path Applies to You?
Find your situation and the recommended approach below.
10+ Years Remaining Life, Multiple Potential Users
Software, AI, communications patent with broad applicability
Licensing is likely the higher-value path. A non-exclusive campaign targeting 5–10 companies in your CPC category at 3–5% royalties can generate significantly more total income than a single sale — especially if multiple companies are already using the technology. Ipiry's AI identifies all potential licensees simultaneously and initiates outreach.
Needs Immediate Liquidity, Short Remaining Life
Patent with under 5 years remaining or low citation count
Sale is better than licensing when remaining life is short. Small royalties over 3–5 years rarely justify the time and complexity of negotiating and managing a license agreement. A lump-sum sale through Ipiry's marketplace closes in 30–90 days and puts money in your account now, rather than small checks for a few years.
Identified a Specific Infringer
Competitor's product appears to use your patented technology
Infringement is the strongest basis for a licensing demand. A company already using your technology without authorization has both economic incentive to license (avoid litigation) and legal exposure that makes negotiation realistic. Build an EoU chart documenting the infringement, then approach with a licensing proposal. This is the fastest path to a signed agreement.
Corporate IP Team with Patent Portfolio
20+ patents across multiple technology categories
Portfolio licensing strategy requires tiering: highest-value patents (G06N, H01L, A61B) for exclusive licensing at premium rates; mid-tier patents for non-exclusive campaigns; lower-tier patents for abandonment to reduce maintenance costs. Ipiry's Portfolio Report ($499) values all 20 patents simultaneously and identifies the optimal licensing vs. sale vs. abandon decision for each.
Frequently Asked Questions
How do I license my patent?
To license a patent, follow five steps: (1) get a patent valuation to establish your royalty anchor; (2) identify potential licensees in your technology sector — companies that make products using your patented method; (3) prepare an evidence-of-use (EoU) chart documenting how each target company's products match your claims; (4) approach the company with a licensing proposal citing your valuation and EoU evidence; (5) negotiate royalty rate, scope, exclusivity, and term, then execute a patent license agreement. Ipiry automates steps 2 and 3.
What is a standard patent royalty rate?
The standard patent royalty rate is 3–10% of net sales of the licensed product, depending on technology category, exclusivity, and the strength of the patent. Software and AI patents (G06F, G06N) typically command 3–5% royalties. Pharmaceutical patents command 5–15%. Semiconductor and hardware patents range from 2–4%. The Georgia-Pacific factors are the standard legal framework for determining a reasonable royalty in patent litigation.
What is the difference between an exclusive and non-exclusive patent license?
An exclusive license gives one licensee the sole right to use the patent in a defined field — no other company can be licensed for that use. A non-exclusive license allows multiple licensees to use the same patent simultaneously, each paying royalties. Exclusive licenses command higher royalty rates (2–3x non-exclusive) but limit your ability to license to additional parties. Most inventors prefer non-exclusive licenses because they preserve income diversification.
How do I find companies to license my patent to?
Identify potential licensees by: (1) searching for products that use the technology your patent covers — this is the same process as infringement detection; (2) reviewing the forward citations on your patent — companies that cite your patent are aware of it and may be infringing or interested in licensing; (3) using Ipiry's AI buyer matching, which identifies companies whose products overlap with your patent's claims. Evidence of actual use is the strongest basis for a licensing approach.
What is a patent license agreement?
A patent license agreement is the legal contract that establishes the terms under which a licensee may use the patent. It must include: the identity of the licensed patents (by number), the scope of the license (exclusive or non-exclusive, field of use, territory), the royalty structure (rate, base, payment frequency), audit rights, sublicense rights or restrictions, term and termination conditions, and representations and warranties. Patent license agreements should be drafted or reviewed by a registered patent attorney.
What is the difference between a running royalty and a lump-sum license?
A running royalty is an ongoing payment calculated as a percentage of sales — the licensee pays as they earn. A lump-sum license is a one-time upfront payment for the right to use the patent for its remaining life. Running royalties are better when the licensee's sales are uncertain or growing; lump-sum is better when you want immediate certainty. A hybrid structure (upfront payment plus running royalty) is common in high-value deals.
Can I license a patent I no longer use?
Yes. You do not need to practice your patent to license it. In fact, non-practicing entities (NPEs) build entire businesses around licensing patents they do not use. The key requirement is that the patent remains active and in force — meaning maintenance fees have been paid and the patent has not expired or been invalidated. A patent can be licensed at any point in its 20-year life.
What is a field-of-use restriction in a patent license?
A field-of-use restriction limits the licensee's right to use the patent to a specific application or market. For example, a patent covering a compression algorithm might be licensed exclusively to one company for video streaming applications, while the same patent is licensed non-exclusively to other companies for data backup applications. Field-of-use restrictions allow patent holders to segment the market and capture maximum value by licensing to multiple companies in different fields without direct competition between licensees.
How much does it cost to license a patent?
The cost to a licensee depends on the royalty structure. Running royalties typically range from 3–10% of net sales. Lump-sum licenses for software patents range from $25,000 to $500,000+ depending on patent value and exclusivity. Some licensees pay both an upfront fee and ongoing royalties. For patent holders, Ipiry's licensing facilitation is free to initiate — Ipiry earns a success fee only when a license closes, similar to the brokerage commission structure.
Do I need a lawyer to license a patent?
You do not need a lawyer to identify licensees, approach companies, or negotiate basic terms. However, a patent license agreement is a legal contract that should be drafted or reviewed by a registered patent attorney. The consequences of poorly drafted agreements — ambiguous scope, missing audit rights, undefined sublicense provisions — can be severe. Use Ipiry to identify and approach licensees; use a patent attorney to draft and execute the agreement.
Start Your Licensing Campaign
Ipiry finds licensees. You keep ownership. Success fee only — paid when a license closes, not before.